- |||||||||| Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK
Trial completion: Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine (clinicaltrials.gov) - Apr 17, 2013
P3, N=214, Completed,
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Vaxelis (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, haemophilus b conjugate and hepatitis B vaccine) / Merck (MSD), Sanofi
Trial completion: Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) (clinicaltrials.gov) - Apr 8, 2013
P3, N=1250, Completed,
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK
Trial completion: Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants (clinicaltrials.gov) - Mar 20, 2013
P4, N=224, Completed,
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK
Trial completion, Pneumococcal vaccines: Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment (clinicaltrials.gov) - Jan 23, 2013
P4, N=850, Completed,
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK
Trial completion: Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) (clinicaltrials.gov) - Nov 7, 2012
P2, N=657, Completed,
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Synflorix (10-valent pneumococcal conjugate vaccine) / GSK, pneumococcal recombinant vaccine (GSK 2189242A) / GSK, Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK
Trial completion, Pneumococcal vaccines: Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants (clinicaltrials.gov) - Oct 10, 2012
P2, N=576, Completed,
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer
Trial completion: NeisVac-C Single Prime Study in Infants (clinicaltrials.gov) - Jul 10, 2012
P3, N=956, Completed,
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Synflorix (10-valent pneumococcal conjugate vaccine) / GSK, Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK
New P2 trial, Pneumococcal vaccines: Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants (clinicaltrials.gov) - Jun 7, 2012
P2, N=953, Completed,
- |||||||||| Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK
Enrollment change: Vaccination of Children Following Allogeneic Stem Cell Transplantation (clinicaltrials.gov) - Jun 5, 2012
P3, N=53, Completed,
Active, not recruiting --> Completed N=81 --> 53
- |||||||||| Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK
Trial completion: Vaccination of Children Following Allogeneic Stem Cell Transplantation (clinicaltrials.gov) - Jun 5, 2012
P3, N=53, Completed,
N=81 --> 53 Active, not recruiting --> Completed
- |||||||||| Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK
Trial completion: Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) (clinicaltrials.gov) - Jan 12, 2012
P2, N=721, Completed,
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Vaxelis (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, haemophilus b conjugate and hepatitis B vaccine) / Merck (MSD), Sanofi
New P3 trial: Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) (clinicaltrials.gov) - Nov 24, 2011
P3, N=1315, Completed,
- |||||||||| Synflorix (10-valent pneumococcal conjugate vaccine) / GSK, Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK
Trial completion, Head-to-Head: Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib (clinicaltrials.gov) - Oct 27, 2011
P3, N=780, Completed,
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK, Rotarix (rotavirus vaccine) / GSK
Trial completion: Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants (clinicaltrials.gov) - Oct 20, 2011
P2, N=480, Completed,
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Pediarix (diphtheria, tetanus toxoids and acellular pertussis adsorbed, hepatitis b and inactivated poliovirus vaccine) / GSK, Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK
New P3 trial: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately (clinicaltrials.gov) - Oct 19, 2011
P3, N=440, Completed,
- |||||||||| Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK
Trial completion: Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children (clinicaltrials.gov) - Oct 13, 2011
P4, N=300, Completed,
Active, not recruiting --> Completed Active, not recruiting --> Completed
|
